Showing results (21-30 of 442) with videos related to
Sort By:
Pageof 45
Current Opinion in Pharmacology|October 11, 2005
Advances in medical therapy of inflammatory bowel diseaseRemo Panaccione, Jose G Ferraz, Paul BeckFrontiers in Pharmacology|December 19, 2019
The Clinical Implications of Nocebo Effects for Biosimilar TherapyLuana Colloca, Remo Panaccione, T Kevin MurphyCurrent Opinion in Gastroenterology|April 25, 2024
A practical guide to combination advanced therapy in inflammatory bowel diseaseChristina M Ray, Remo Panaccione, Christopher MaTherapeutic Advances in Gastroenterology|December 25, 2010
Efficacy and safety of adalimumab in Crohn's diseaseGary R Lichtenstein, Remo Panaccione, Gordon MallarkeyNature Reviews. Gastroenterology & Hepatology|February 6, 2010
Optimizing the safety of biologic therapy for IBDShanika de Silva, Shane Devlin, Remo PanaccioneTherapeutic Advances in Gastroenterology|June 23, 2011
Exploring the role of monitoring anti-TNFα drug and antibody levels in the management of inflammatory bowel diseaseAllen W Lim, Remo Panaccione, Cynthia H SeowInfectious Disease Clinics of North America|October 13, 2010
Influences of intestinal bacteria in human inflammatory bowel diseaseRachel Vanderploeg, Remo Panaccione, Subrata Ghosh, et al.Therapeutic Advances in Gastroenterology|July 19, 2011
Optimizing clinical use of mesalazine (5-aminosalicylic acid) in inflammatory bowel diseaseChadwick Williams, Remo Panaccione, Subrata Ghosh, et al.Digestive Diseases and Sciences|October 13, 2007
Exposing the weaknesses: a systematic review of azathioprine efficacy in ulcerative colitisYvette Leung, Remo Panaccione, Brenda Hemmelgarn, et al.Journal of the Canadian Association of Gastroenterology|February 14, 2023
Innovative Care for Inflammatory Bowel Disease Patients during the COVID-19 Pandemic: Use of Bedside Intestinal Ultrasound to Optimize ManagementCathy Lu, Christopher Ma, Richard J M Ingram, et al.Pageof 45